KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DXC Technology (DXC) Cash & Equivalents (2017 - 2025)

DXC Technology (DXC) has 9 years of Cash & Equivalents data on record, last reported at $1.7 billion in Q4 2025.

  • For Q4 2025, Cash & Equivalents changed 0.46% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $1.7 billion, changed 0.46%, while the annual FY2025 figure was $1.8 billion, 46.73% up from the prior year.
  • Cash & Equivalents reached $1.7 billion in Q4 2025 per DXC's latest filing, down from $1.9 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $3.0 billion in Q1 2021 and bottomed at $1.2 billion in Q1 2024.
  • Average Cash & Equivalents over 5 years is $2.0 billion, with a median of $1.8 billion recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: plummeted 55.35% in 2021, then surged 51.65% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $2.9 billion in 2021, then decreased by 28.37% to $2.1 billion in 2022, then fell by 19.13% to $1.7 billion in 2023, then grew by 1.89% to $1.7 billion in 2024, then rose by 0.46% to $1.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $1.7 billion in Q4 2025, $1.9 billion in Q3 2025, and $1.8 billion in Q2 2025.